相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
Daniela Sia et al.
GASTROENTEROLOGY (2017)
Mechanisms of hepatic stellate cell activation
Takuma Tsuchida et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
TGFB-induced transcription in cancer
Gaia Cantelli et al.
SEMINARS IN CANCER BIOLOGY (2017)
Precision medicine for hepatocelluar carcinoma using molecular pattern diagnostics: results from a preclinical pilot study
Rahul Agarwal et al.
CELL DEATH & DISEASE (2017)
Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical study
Rosina Critelli et al.
CELL DEATH & DISEASE (2017)
Transforming growth factor-β-induced plasticity causes a migratory sternness phenotype in hepatocellular carcinoma
Andrea Malfettone et al.
CANCER LETTERS (2017)
The rationale for targeting TGF-β in chronic liver diseases
Gianluigi Giannelli et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2016)
Role of epithelial to mesenchymal transition in hepatocellular carcinoma
Gianluigi Giannelli et al.
JOURNAL OF HEPATOLOGY (2016)
Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target
Yongmin Yan et al.
STEM CELLS TRANSLATIONAL MEDICINE (2015)
A mesenchymal-like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cells
Joan Fernando et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Moving towards personalised therapy in patients with hepatocellular carcinoma: the role of the microenvironment
Gianluigi Giannelli et al.
GUT (2014)
Overactivation of the TGF-β Pathway Confers a Mesenchymal-Like Phenotype and CXCR4-Dependent Migratory Properties to Liver Tumor Cells
Esther Bertran et al.
HEPATOLOGY (2013)
Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II
Francesco Dituri et al.
PLOS ONE (2013)
Efficacy of Using Cancer Stem Cell Markers in Isolating and Characterizing Liver Cancer Stem Cells
George S. Wilson et al.
STEM CELLS AND DEVELOPMENT (2013)
Epithelial-mesenchymal transition expression profiles as a prognostic factor for disease-free survival in hepatocellular carcinoma: Clinical significance of transforming growth factor-β signaling
Kosuke Mima et al.
ONCOLOGY LETTERS (2013)
CD44s Regulates the TGF-β-Mediated Mesenchymal Phenotype and Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma
Kosuke Mima et al.
CANCER RESEARCH (2012)
TGF-β control of stem cell differentiation genes
Joan Massague et al.
FEBS LETTERS (2012)
TGFβ signalling in context
Joan Massague
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations
Xiaoli Chen et al.
JOURNAL OF HEPATOLOGY (2011)
Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets
Tamara Severi et al.
ACTA PHARMACOLOGICA SINICA (2010)
Pathology of Early Hepatocellular Carcinoma: Conventional and Molecular Diagnosis
Tania Roskams et al.
SEMINARS IN LIVER DISEASE (2010)
Transforming growth factor-β gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer
Cedric Coulouarn et al.
HEPATOLOGY (2008)
Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells
Emilia Fransvea et al.
HEPATOLOGY (2008)
CD13 is a novel mediator of monocytic/endothelial cell adhesion
Paola Mina-Osorio et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Alpha fetoprotein, ultrasound, computerized tomography and magnetic resonance imaging for detection of hepatocellular carcinoma in patients with advanced cirrhosis
N. Snowberger et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
分享论文
